Literature DB >> 24148273

Striatal dopaminergic dysfunction at rest and during task performance in writer's cramp.

Brian D Berman1, Mark Hallett, Peter Herscovitch, Kristina Simonyan.   

Abstract

Writer's cramp is a task-specific focal hand dystonia characterized by involuntary excessive muscle contractions during writing. Although abnormal striatal dopamine receptor binding has been implicated in the pathophysiology of writer's cramp and other primary dystonias, endogenous dopamine release during task performance has not been previously investigated in writer's cramp. Using positron emission tomography imaging with the D2/D3 antagonist 11C-raclopride, we analysed striatal D2/D3 availability at rest and endogenous dopamine release during sequential finger tapping and speech production tasks in 15 patients with writer's cramp and 15 matched healthy control subjects. Compared with control subjects, patients had reduced 11C-raclopride binding to D2/D3 receptors at rest in the bilateral striatum, consistent with findings in previous studies. During the tapping task, patients had decreased dopamine release in the left striatum as assessed by reduced change in 11C-raclopride binding compared with control subjects. One cluster of reduced dopamine release in the left putamen during tapping overlapped with a region of reduced 11C-raclopride binding to D2/D3 receptors at rest. During the sentence production task, patients showed increased dopamine release in the left striatum. No overlap between altered dopamine release during speech production and reduced 11C-raclopride binding to D2/D3 receptors at rest was seen. Striatal regions where D2/D3 availability at rest positively correlated with disease duration were lateral and non-overlapping with striatal regions showing reduced D2/D3 receptor availability, except for a cluster in the left nucleus accumbens, which showed a negative correlation with disease duration and overlapped with striatal regions showing reduced D2/D3 availability. Our findings suggest that patients with writer's cramp may have divergent responses in striatal dopamine release during an asymptomatic motor task involving the dystonic hand and an unrelated asymptomatic task, sentence production. Our voxel-based results also suggest that writer's cramp may be associated with reduced striatal dopamine release occuring in the setting of reduced D2/D3 receptor availability and raise the possibility that basal ganglia circuits associated with premotor cortices and those associated with primary motor cortex are differentially affected in primary focal dystonias.

Entities:  

Keywords:  PET; dopamine; dystonia; raclopride; striatum

Mesh:

Substances:

Year:  2013        PMID: 24148273      PMCID: PMC3859223          DOI: 10.1093/brain/awt282

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  91 in total

1.  Improved optimization for the robust and accurate linear registration and motion correction of brain images.

Authors:  Mark Jenkinson; Peter Bannister; Michael Brady; Stephen Smith
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

2.  Mapping the basal ganglia: fMRI evidence for somatotopic representation of face, hand, and foot.

Authors:  L Maillard; K Ishii; K Bushara; D Waldvogel; A E Schulman; M Hallett
Journal:  Neurology       Date:  2000-08-08       Impact factor: 9.910

3.  Botulinum toxin for writer's cramp: a randomised, placebo-controlled trial and 1-year follow-up.

Authors:  J J M Kruisdijk; J H T M Koelman; B W Ongerboer de Visser; R J de Haan; J D Speelman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-21       Impact factor: 10.154

4.  Cerebral and cerebellar activation in correlation to the action-induced dystonia in writer's cramp.

Authors:  T Odergren; S Stone-Elander; M Ingvar
Journal:  Mov Disord       Date:  1998-05       Impact factor: 10.338

5.  Botulinum toxin in writer's cramp: objective response evaluation in 31 patients.

Authors:  J Wissel; C Kabus; R Wenzel; S Klepsch; U Schwarz; A Nebe; L Schelosky; U Scholz; W Poewe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

Review 6.  Pathophysiology of dystonia.

Authors:  M Hallett
Journal:  J Neural Transm Suppl       Date:  2006

7.  Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia.

Authors:  Chang-Hyun Song; Xueliang Fan; Cicely J Exeter; Ellen J Hess; H A Jinnah
Journal:  Neurobiol Dis       Date:  2012-05-31       Impact factor: 5.996

Review 8.  The pathophysiological basis of dystonias.

Authors:  Xandra O Breakefield; Anne J Blood; Yuqing Li; Mark Hallett; Phyllis I Hanson; David G Standaert
Journal:  Nat Rev Neurosci       Date:  2008-03       Impact factor: 34.870

9.  Decreased dopamine D receptor binding in essential blepharospasm.

Authors:  C Horie; Y Suzuki; M Kiyosawa; M Mochizuki; M Wakakura; K Oda; K Ishiwata; K Ishii
Journal:  Acta Neurol Scand       Date:  2008-06-05       Impact factor: 3.209

10.  "Motor circuit" gray matter changes in idiopathic cervical dystonia.

Authors:  B Draganski; C Thun-Hohenstein; U Bogdahn; J Winkler; A May
Journal:  Neurology       Date:  2003-11-11       Impact factor: 9.910

View more
  26 in total

1.  Abnormal striatal dopaminergic neurotransmission during rest and task production in spasmodic dysphonia.

Authors:  Kristina Simonyan; Brian D Berman; Peter Herscovitch; Mark Hallett
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

Review 2.  Neuroimaging Applications in Dystonia.

Authors:  Kristina Simonyan
Journal:  Int Rev Neurobiol       Date:  2018-10-23       Impact factor: 3.230

3.  Accumulation of rare variants in the arylsulfatase G (ARSG) gene in task-specific dystonia.

Authors:  Esther Nibbeling; Susen Schaake; Marina A Tijssen; Anne Weissbach; Justus L Groen; Eckart Altenmüller; Dineke S Verbeek; Katja Lohmann
Journal:  J Neurol       Date:  2015-04-01       Impact factor: 4.849

4.  Hemodynamic responses are abnormal in isolated cervical dystonia.

Authors:  Brian D Berman; Christopher L Groth; Erica Shelton; Stefan H Sillau; Brianne Sutton; Kristina T Legget; Jason R Tregellas
Journal:  J Neurosci Res       Date:  2019-11-06       Impact factor: 4.164

Review 5.  The neurobiological basis for novel experimental therapeutics in dystonia.

Authors:  Anthony M Downs; Kaitlyn M Roman; Simone A Campbell; Antonio Pisani; Ellen J Hess; Paola Bonsi
Journal:  Neurobiol Dis       Date:  2019-07-04       Impact factor: 5.996

6.  Polygenic Risk of Spasmodic Dysphonia is Associated With Vulnerable Sensorimotor Connectivity.

Authors:  Gregory Garbès Putzel; Giovanni Battistella; Anna F Rumbach; Laurie J Ozelius; Mert R Sabuncu; Kristina Simonyan
Journal:  Cereb Cortex       Date:  2018-01-01       Impact factor: 5.357

7.  Task-specific interhemispheric hypoconnectivity in writer's cramp - An EEG study.

Authors:  Nivethida Thirugnanasambandam; Tyler Zimmerman; Ajay S Pillai; Jessica Shields; Silvina G Horovitz; Mark Hallett
Journal:  Clin Neurophysiol       Date:  2020-02-04       Impact factor: 3.708

Review 8.  Molecular imaging of movement disorders.

Authors:  Karlo J Lizarraga; Alessandra Gorgulho; Wei Chen; Antonio A De Salles
Journal:  World J Radiol       Date:  2016-03-28

9.  ADCY5-related dyskinesia: Broader spectrum and genotype-phenotype correlations.

Authors:  Dong-Hui Chen; Aurélie Méneret; Jennifer R Friedman; Olena Korvatska; Alona Gad; Emily S Bonkowski; Holly A Stessman; Diane Doummar; Cyril Mignot; Mathieu Anheim; Saunder Bernes; Marie Y Davis; Nathalie Damon-Perrière; Bertrand Degos; David Grabli; Domitille Gras; Fuki M Hisama; Katherine M Mackenzie; Phillip D Swanson; Christine Tranchant; Marie Vidailhet; Steven Winesett; Oriane Trouillard; Laura M Amendola; Michael O Dorschner; Michael Weiss; Evan E Eichler; Ali Torkamani; Emmanuel Roze; Thomas D Bird; Wendy H Raskind
Journal:  Neurology       Date:  2015-11-04       Impact factor: 9.910

10.  Dopamine Receptor Agonist Treatment of Idiopathic Dystonia: A Reappraisal in Humans and Mice.

Authors:  Xueliang Fan; Yuping Donsante; H A Jinnah; Ellen J Hess
Journal:  J Pharmacol Exp Ther       Date:  2018-01-18       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.